miércoles, 15 de octubre de 2025

World Heart Day: diabetes and cardiovascular risk The Lancet Diabetes & Endocrinology + + +...

https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00296-7/fulltext?dgcid=raven_jbs_etoc_email Once-weekly semaglutide 7·2 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial https://www.thelancet.com/journals/landia/article/PIIS2213-8587(25)00226-8/abstract?dgcid=raven_jbs_etoc_feature_landia Comment p898 Peripheral CB1 receptor blockade for treatment of obesity Kishore M Gadde,Jonanne Talebloo,Daniele Piomelli https://www.thelancet.com/journals/landia/issue/vol13no11/PIIS2213-8587(25)X0011-5

No hay comentarios:

Publicar un comentario